---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-074164"
form_type: "8-K"
ticker: "UNCY"
cik: "0001766140"
company_name: "Unicycive Therapeutics, Inc."
filed_at: "2023-09-06T23:59:59+00:00"
generated_at: "2026-06-10T23:31:02.782586+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Unicycive Therapeutics appoints veteran drug developer Sara Kenkare-Mitra to board

## Summary
- Appointed Sara Kenkare-Mitra, PhD as independent director effective September 6, 2023.
- Dr. Kenkare-Mitra is President & Head of R&D at Alector; previously 23 years at Genentech as SVP.
- She played key role in >100 IND/CTA filings and 11 drug approvals across multiple diseases.
- Her expertise expected to help advance oxylanthanum carbonate toward NDA filing and UNI-494 IND.

## SEC filing metadata
- accession: 0001213900-23-074164
- form_type: 8-K
- ticker: UNCY
- cik: 0001766140
- company_name: Unicycive Therapeutics, Inc.
- filed_at: 2023-09-06T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1766140/000121390023074164/0001213900-23-074164-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1766140/000121390023074164/ea184727-8k_unicycive.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-074164
- JSON: https://secwatch.observer/filing/0001213900-23-074164.json
- Plain text: https://secwatch.observer/filing/0001213900-23-074164.txt

## Key facts
- Executive change
  Sara Kenkare-Mitra was appointed as Independent Director at Unicycive Therapeutics, Inc..
  - Action: appointed
  - Role: Independent Director
  source text: On September 5, 2023, Unicycive Therapeutics, Inc. (the “Company”) appointed Sara Kenkare-Mitra as an independent director.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1766140/000121390023074164/0001213900-23-074164-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.